Context Therapeutics Inc. (CNTX)

NASDAQ: CNTX · IEX Real-Time Price · USD
1.382
+0.142 (11.45%)
At close: Mar 27, 2024, 4:00 PM
1.398
+0.016 (1.16%)
Pre-market: Mar 28, 2024, 8:12 AM EDT

Total Valuation

CNTX has a market cap or net worth of $22.07 million. The enterprise value is $7.62 million.

Market Cap 22.07M
Enterprise Value 7.62M

Important Dates

The last earnings date was Thursday, March 21, 2024, before market open.

Earnings Date Mar 21, 2024
Ex-Dividend Date n/a

Share Statistics

CNTX has 15.97 million shares outstanding.

Shares Outstanding 15.97M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 6.86%
Owned by Institutions (%) 30.06%
Float 13.89M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.86
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.83, with zero debt.

Current Ratio 3.83
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -115.50% and return on invested capital (ROIC) is -211.68%.

Return on Equity (ROE) -115.50%
Return on Assets (ROA) -97.00%
Return on Capital (ROIC) -211.68%
Revenue Per Employee n/a
Profits Per Employee -$4.79M
Employee Count 5
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +113.72% in the last 52 weeks. The beta is 2.13, so CNTX's price volatility has been higher than the market average.

Beta (1Y) 2.13
52-Week Price Change +113.72%
50-Day Moving Average 1.11
200-Day Moving Average 1.12
Relative Strength Index (RSI) 67.42
Average Volume (30 Days) 45,414

Short Selling Information

The latest short interest is 17,003, so 0.11% of the outstanding shares have been sold short.

Short Interest 17,003
Short Previous Month 10,782
Short % of Shares Out 0.11%
Short % of Float 0.12%
Short Ratio (days to cover) 0.33

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -25.13M
Pretax Income -23.96M
Net Income -23.96M
EBITDA -23.90M
EBIT -23.96M
Earnings Per Share (EPS) -$1.50
Full Income Statement

Balance Sheet

The company has $14.45 million in cash and no debt, giving a net cash position of $14.45 million or $0.91 per share.

Cash & Cash Equivalents 14.45M
Total Debt n/a
Net Cash 14.45M
Net Cash Per Share $0.91
Equity / Book Value 11.87M
Book Value Per Share 0.74
Working Capital 11.86M
Full Balance Sheet

Cash Flow

Operating Cash Flow -21.05M
Capital Expenditures n/a
Free Cash Flow -21.05M
FCF Per Share -$1.32
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -108.61%
FCF Yield -95.39%

Analyst Forecast

The average price target for CNTX is $4.00, which is 189.44% higher than the current price. The consensus rating is "Strong Buy".

Price Target $4.00
Price Target Difference 189.44%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -7.99%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1